SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 535 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,372,914 | -33.5% | 11,185 | -39.7% | 0.00% | -40.0% |
| Q2 2023 | $3,569,911 | -26.8% | 18,549 | -23.0% | 0.01% | -28.6% |
| Q1 2023 | $4,876,476 | +35.0% | 24,085 | -14.3% | 0.01% | +40.0% |
| Q4 2022 | $3,611,621 | -2.1% | 28,103 | +4.2% | 0.01% | -16.7% |
| Q3 2022 | $3,689,000 | -20.9% | 26,963 | +2.3% | 0.01% | -14.3% |
| Q2 2022 | $4,663,000 | +22.6% | 26,358 | -0.2% | 0.01% | +40.0% |
| Q1 2022 | $3,803,000 | -8.3% | 26,401 | -1.5% | 0.01% | 0.0% |
| Q4 2021 | $4,146,000 | -9.7% | 26,811 | -0.9% | 0.01% | -28.6% |
| Q3 2021 | $4,591,000 | +8.9% | 27,041 | +1.3% | 0.01% | +16.7% |
| Q2 2021 | $4,216,000 | +13.5% | 26,705 | -0.1% | 0.01% | 0.0% |
| Q1 2021 | $3,713,000 | -60.1% | 26,742 | -49.7% | 0.01% | -64.7% |
| Q4 2020 | $9,317,000 | – | 53,197 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |